Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Vascular Calcification in PD Patients
NCT00299572Phase 4Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alendronate in Vascular calcification and osteoporosis (2 arms), sponsored by Far Eastern Memorial Hospital. Primary endpoints: Changes of calcification score of coronary arteries at 32 weeks, Changes of calcification score of aorta at 32 weeks and 1 more. Status: unknown.
02
Drugs
alendronate
03
Conditions
Vascular calcificationosteoporosis
Beyond the preview
Go deeper on NCT00299572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299572.